News
Videos
Conferences
Events
Resources
Subscribe

Opinion|Videos|November 21, 2023

Unmet Needs in the Cervical Cancer Treatment Landscape

Author(s)Claire Friedman, MD, Emily Davan, RN, Linda Ryan

The panel discusses unmet needs in the treatment landscape for patients with cervical cancer and the importance of clinical trials.

Episodes in this series

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 1 Overview of Cervical Cancer

Linda Ryan, a patient advocate

EP. 2 Cervical Cancer: The Patient Journey

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 3 Patient Perceptions of Cervical Cancer Screening

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 4 Treatment Options for Patients With Primary or Recurrent Cervical Cancer

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 5 Treatments for Patients With Newly Diagnosed Metastatic Cervical Cancer

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 6 Individualized Treatment Selection in Cervical Cancer

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 7 Tisotumab Vedotin for Patients With Cervical Cancer

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 8 Unmet Needs in the Cervical Cancer Treatment Landscape

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 9 Shared Decision-Making in Cervical Cancer

Linda Ryan, a patient advocate

EP. 10 Cervical Cancer: Advocating for Yourself and Communicating With Family

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 11 Cervical Cancer: Insight into the Patient Experience

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 12 Myths Around Cervical Cancer

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Image of woman.

Stage 2 Cervical Cancer: Key Facts and Updates for Patients

November 4th 2025

Image of uterus.

Camrelizumab Combo Extends Survival in Metastatic Cervical Cancer

October 20th 2025

Patient Perspectives on Learning About Their HNSCC

ByGlenn Hanna, MD,Andrew Dunning

September 22nd 2025

Expert Overview of Recurrent/Metastatic HNSCC

ByGlenn Hanna, MD,Andrew Dunning

September 22nd 2025

Final Thoughts and Hope for a Cure

ByAmrita Krishnan, MD,Cherry Rudge, NP,Todd Kennedy ,Diane Kennedy

August 12th 2025

Trending on CURE

B7-H3 CAR T-Cell Therapy Shows Acceptable Safety in Recurrent Glioblastoma

Eflornithine Plus Gleostine Improves Progression, Survival In Some With Astrocytoma

FDA Approves Keytruda and Padcev for Muscle Invasive Bladder Cancer

Voranigo Plus Temodar Found to Be Safe in Patients With IDH1/2+ Glioma

Effective Early Treatments Needed in Glioma, Real-World Data Finds

© 2025 MJH Life Sciences^®

All rights reserved.